These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 2208170)

  • 1. Selective reduction of cis-diamminedichloroplatinum(II) nephrotoxicity by ebselen.
    Baldew GS; McVie JG; van der Valk MA; Los G; de Goeij JJ; Vermeulen NP
    Cancer Res; 1990 Nov; 50(21):7031-6. PubMed ID: 2208170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selenium-induced protection against cis-diamminedichloroplatinum(II) nephrotoxicity in mice and rats.
    Baldew GS; van den Hamer CJ; Los G; Vermeulen NP; de Goeij JJ; McVie JG
    Cancer Res; 1989 Jun; 49(11):3020-3. PubMed ID: 2720662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ebselen attenuates cisplatin-induced ROS generation through Nrf2 activation in auditory cells.
    Kim SJ; Park C; Han AL; Youn MJ; Lee JH; Kim Y; Kim ES; Kim HJ; Kim JK; Lee HK; Chung SY; So H; Park R
    Hear Res; 2009 May; 251(1-2):70-82. PubMed ID: 19286452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time dependence of the selective modulation of cisplatin-induced nephrotoxicity by WR2721 in the mouse.
    Treskes M; Boven E; Holwerda U; Pinedo HM; van der Vijgh WJ
    Cancer Res; 1992 Apr; 52(8):2257-60. PubMed ID: 1313740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of acute cisplatin ototoxicity and nephrotoxicity in rats by oral administration of allopurinol and ebselen.
    Lynch ED; Gu R; Pierce C; Kil J
    Hear Res; 2005 Mar; 201(1-2):81-9. PubMed ID: 15721563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extract of Prunus persica flesh (PPFE) improves chemotherapeutic efficacy and protects against nephrotoxicity in cisplatin-treated mice.
    Lee CK; Park KK; Hwang JK; Lee SK; Chung WY
    Phytother Res; 2009 Jul; 23(7):999-1005. PubMed ID: 19140122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of active hexose correlated compound (AHCC) on cisplatin-evoked chemotherapeutic and side effects in tumor-bearing mice.
    Hirose A; Sato E; Fujii H; Sun B; Nishioka H; Aruoma OI
    Toxicol Appl Pharmacol; 2007 Jul; 222(2):152-8. PubMed ID: 17555784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on protective effect of selenium on the nephrotoxicity of cis-diamminedichloroplatinum (CDDP) in mice].
    Araya Y
    Hokkaido Igaku Zasshi; 1990 May; 65(3):245-53. PubMed ID: 2165995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective protection against cis-diamminedichloroplatinum(II)-induced toxicity in kidney, gut, and bone marrow by diethyldithiocarbamate.
    Bodenner DL; Dedon PC; Keng PC; Katz JC; Borch RF
    Cancer Res; 1986 Jun; 46(6):2751-5. PubMed ID: 3009000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of ebselen, a selenoorganic drug, against gentamicin-induced renal damage in rats.
    Dhanarajan R; Abraham P; Isaac B
    Basic Clin Pharmacol Toxicol; 2006 Sep; 99(3):267-72. PubMed ID: 16930301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
    Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time dependent protection of amifostine from renal and hematopoietic cisplatin induced toxicity.
    Asna N; Lewy H; Ashkenazi IE; Deutsch V; Peretz H; Inbar M; Ron IG
    Life Sci; 2005 Mar; 76(16):1825-34. PubMed ID: 15698860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of cisplatin nephrotoxicity by sodium selenite. Lack of interaction at the pharmacokinetic level of both compounds.
    Vermeulen NP; Baldew GS; Los G; McVie JG; De Goeij JJ
    Drug Metab Dispos; 1993; 21(1):30-6. PubMed ID: 8095223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of selenium in combination with cis-diamminedichloroplatinum(II) in the treatment of murine fibrosarcoma.
    Berry JP; Pauwells C; Tlouzeau S; Lespinats G
    Cancer Res; 1984 Jul; 44(7):2864-8. PubMed ID: 6539165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity, induction of cross-resistance, and nephrotoxicity of a new platinum analogue, cis-1,1-diaminomethylcyclohexaneplatinum(II) sulfate, and of cis-diamminedichloroplatinum(II) in an immunocytoma model in the LOU/M rat.
    de Jong WH; Steerenberg PA; Vos JG; Bulten EJ; Verbeek F; Kruizinga W; Ruitenberg EJ
    Cancer Res; 1983 Oct; 43(10):4927-34. PubMed ID: 6683993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Luteolin ameliorates cisplatin-induced nephrotoxicity in mice through inhibition of platinum accumulation, inflammation and apoptosis in the kidney.
    Domitrović R; Cvijanović O; Pugel EP; Zagorac GB; Mahmutefendić H; Škoda M
    Toxicology; 2013 Aug; 310():115-23. PubMed ID: 23770416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection by ebselen against cisplatin-induced nephrotoxicity: antioxidant system.
    Husain K; Morris C; Whitworth C; Trammell GL; Rybak LP; Somani SM
    Mol Cell Biochem; 1998 Jan; 178(1-2):127-33. PubMed ID: 9546591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of nephrotoxicity of cisplatin by repeated oral administration of ebselen in rats.
    Yoshida M; Iizuka K; Terada A; Hara M; Nishijima H; Akinori ; Shimada ; Nakada K; Satoh Y; Akama Y
    Tohoku J Exp Med; 2000 Aug; 191(4):209-20. PubMed ID: 11038013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrphostin 4-nitrobenzylidene malononitrile reduces chemotherapy toxicity without impairing efficacy.
    Novogrodsky A; Weisspapir M; Patya M; Meshorer A; Vanichkin A
    Cancer Res; 1998 Jun; 58(11):2397-403. PubMed ID: 9622080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.